Navigation Links
Death Risk Of Ovarian Cancer Reduced By Intraperitoneal Chemotherapy

Direct injection of chemotherapeutic agents into directly into the body cavity rather than the conventional intravenous route, seems to be // associated with an improved prognosis of ovarian cancer patients, according to a latest study. //

Ovarian cancer is the fourth leading cause of death among American women. In line with the above finding, the US government has recommended this new form of treatment for all ovarian cancer patients.

This new treatment modality can be difficult to tolerate, but promises an improved average survival rate of nearly 16 months and a 25% reduction in the associated death risk. The results of this study represent one of the largest benefits ever observed for a new therapy in gynecologic oncology, in the opinion of Stephen Cannistra, editor of the New England Journal of Medicine.

"It's very good news. A lot of larger institutions have already adopted this approach. At least for today, this is the best thing we can offer our patients ", said Deborah Armstrong, chief author of the study.

The only surgical option left for patients with advanced ovarian cancer is the removal of most of the visible tumor followed by infusion of chemotherapeutic agents. Most women who receive this form of treatment die within two to three years.

Researchers at the Johns Hopkins Kimmel Cancer Center initiated a study, in an attempt to change the condition. 415 patients with an ovarian cancer diagnosis were taken up for the study. Among the participants, 210 received standard chemotherapy with cisplatin and paclitaxel, while another 205 received the new form of treatment.

The chemotherapeutic agent was directly injected into the body cavity, along with sterile water in such a way that it flushed the entire peritoneum. This was repeated another five times, with a minimum duration of three weeks between each session. It was found that these women survived for 66 months that meant a
'"/>




Page: 1 2

Related medicine news :

1. White Cells Count Can Predict Heart Attack Death Risk
2. Bayer Voluntarily Withdraws BAYCOL - A Drug Associated With 50 Deaths
3. AIDS toll set to exceed Black Death
4. Fish Oil Fights Arrhythmias, Sudden Death
5. Painkiller Linked to Deaths
6. Death due to premature heartbeat after exercise
7. Preventing Childhood Deaths
8. Death Risk Higher in Obese Women with Colon Cancer
9. Death Among the Homeless
10. Diabetes on the Increase but Death Rate Falling
11. Drug Users and Risk of Death
Post Your Comments:
(Date:7/25/2008)... Authority offers patients consumers tips and enco...nt safety, HARRISBURG, Pa., July 25 /PRNewswire-U...ority today supports "National Patient Safety Day"...and their families to,participate fully in their h...ing they can about their surgery or illness., "We...
(Date:7/25/2008)... - 180-Days of Marketing Exclusivity Begin...l/ -- Watson,Pharmaceuticals, Inc. (NYSE: WPI ), ...ced today that its subsidiary has commenced commer...psules USP product in the 40mg,strength from its D...on,with the launch, Watson has 180 days of marketi...
(Date:7/25/2008)...ck to benefit ALS Therapy Alliance to be presented...ight, WOONSOCKET, R.I., July 25 /PRNewswire/ -- C...raised a record-breaking $4.4 million in just 21 d...gn for ALS research. This is,the seventh year of t...aised more than $15 million for ALS research. This...
(Date:7/25/2008)... The Retina Group of New York wi...lated macular degeneration especially designed for...ale Public Library at 116 Merritts Road, Farmingda...15. Attendance is free and refreshments will be pr...516) 939-6100. , Hicksvil...
Breaking Medicine News(10 mins):Health News:Patient Safety Authority Supports 'National Patient Safety Day' 2Health News:Patient Safety Authority Supports 'National Patient Safety Day' 3Health News:Watson Launches Omeprazole Delayed-Release Capsules, 40MG 2Health News:CVS/pharmacy Raises Record-breaking $4.4 Million for ALS Research Through Annual ALS Fundraising Campaign 2Health News:Retina Group of New York To Present Seminar on Age-Related Macular Degeneration; The Leading Cause of Visual Loss in Seniors 2Health News:Retina Group of New York To Present Seminar on Age-Related Macular Degeneration; The Leading Cause of Visual Loss in Seniors 3
...ector-General N. K. Ganguly on Friday launched The...linical trials conducted in India would be registe...of new drugs. The national registry will make the...t. It is the first such initiative in Asia. Any r...
...deputy has called on the Chinese Government to int...uggestive commercials, at least during the summer ...o have been convinced about this after hearing her...at she would never eat cakes because boys don't li...
...ry, Queen of Scots once slept, but the price for d...ng to The Scotsman,Lennoxlove House, set in 460 ac...Scotland's most powerful families, and from this w...able to hire. Guests in its 11 bedrooms will slee...
...ter book only hours away now, helplines are gearin...er fans. Childline, a free helpline for children...a shifts prior to the launch of Harry Potter and t...uly 21. The helpline has predicted that many youn...
Other Medicine News:Health News:Clinical Trials Registry Launched in India 2
(Date:7/23/2008)...lication in July print edition of Clinical ...APOLIS, July 23 /- A Roche Diagnostic...rminal pro-B-type natriuretic peptide,(NT-proBNP) ...,stratification in predicting the risk of cardiova...with non-steroidal anti-inflammatory drugs of,the ...
(Date:7/23/2008)...RNewswire/ -- InCode BioPharmaceutics, Inc.,an em...preclinical test,results demonstrating the utility...ent of the rare chronic blood disorder paroxysmal ...ts will be presented at the XXII,International Com...28,2008., The only treatment currently available...
(Date:7/22/2008)...ewswire/ -- Nonin Medical, a leading innovator,of ...0 years, has entered,the clinical testing phase wi... oxygen saturation. Today,s most common applicatio... of the regional blood oxygenation,in the brain --...mes from an ongoing clinical study at the,Duke Uni...
(Date:7/22/2008)...tus(R) and Apidra(R) Resulted in Significant, Redu...atever the Algorithm ... -- Results from the "Adjust to,Target in Type 2 D...hydrate,Counting for Adjustment of Mealtime Insuli... Diabetes Association,s (ADA) medical journal,Dia...
Breaking Medicine Technology:Study Reveals Potential for NT-proBNP as a Marker to Predict Cardiovascular Risks From Anti-Inflammatory Drugs 2Study Reveals Potential for NT-proBNP as a Marker to Predict Cardiovascular Risks From Anti-Inflammatory Drugs 3Study Reveals Potential for NT-proBNP as a Marker to Predict Cardiovascular Risks From Anti-Inflammatory Drugs 4InCode BioPharmaceutics, Inc. Announces Key Data Supporting New Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH) 2Nonin Medical Inc. Announces Entry Into the Cerebral Oximeter Market 2Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 2Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 3Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 4Zero Calorie Aqua Lyte 28R 29 Hydrates as Well as Traditional Sports Drinks 20646 1Zero Calorie Aqua Lyte 28R 29 Hydrates as Well as Traditional Sports Drinks 20646 2Zero Calorie Aqua Lyte 28R 29 Hydrates as Well as Traditional Sports Drinks 20646 3NARSAD Researchers Identify Specific Genes and Family Traits Linked to Schizophrenia Bipolar Disorder and Depression 2233 1NARSAD Researchers Identify Specific Genes and Family Traits Linked to Schizophrenia Bipolar Disorder and Depression 2233 2NARSAD Researchers Identify Specific Genes and Family Traits Linked to Schizophrenia Bipolar Disorder and Depression 2233 3NARSAD Researchers Identify Specific Genes and Family Traits Linked to Schizophrenia Bipolar Disorder and Depression 2233 4NARSAD Researchers Identify Specific Genes and Family Traits Linked to Schizophrenia Bipolar Disorder and Depression 2233 5NARSAD Researchers Identify Specific Genes and Family Traits Linked to Schizophrenia Bipolar Disorder and Depression 2233 6Presentation of Data on Progens Cancer Epigenetic Targets Platform 2231 1Presentation of Data on Progens Cancer Epigenetic Targets Platform 2231 2Presentation of Data on Progens Cancer Epigenetic Targets Platform 2231 3Young adults at risk 3A 13 7 million lack health insurance coverage 20641 1Young adults at risk 3A 13 7 million lack health insurance coverage 20641 2Young adults at risk 3A 13 7 million lack health insurance coverage 20641 3
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
Medicine Products: